Top Markets
Coin of the day
Lexaria Bioscience Corp. Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXW
Rang in Aktien #41277
Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation... Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
Aktienkurs
$0.0012
Zuletzt synchronisiert: 2026-01-13
Marktkapitalisierung
$29.83K
Veränderung (1 Tag)
-77.36%
Veränderung (1 Jahr)
-98.91%
Land
US
Handel Lexaria Bioscience Corp. (LEXXW)

Kategorie

Preis LEXXW mit Marktkapitalisierung von B
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
LEXXW
$0.0012
Marktkapitalisierung von Lexaria Bioscience Corp.(LEXXW)
Marktkapitalisierung: $29.83K
Mit Stand August 2026 hat Lexaria Bioscience Corp. eine Marktkapitalisierung von $29.83K. Das macht Lexaria Bioscience Corp. laut unseren Daten zum 41277th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Lexaria Bioscience Corp. von 2021 bis 2026
LEXXW im Vergleich zu den Top 5 der beliebtesten stocks
Preis für LEXXW Vermögenswert B Marktkapitalisierung von B Ergebnisse
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
$216,576 $29.83K
$5.383T +18,048,007,156.22%
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
$177,956 $29.83K
$4.423T +14,829,661,031.74%
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
$167,374 $29.83K
$4.160T +13,947,866,034.72%
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
$147,378 $29.83K
$3.663T +12,281,483,523.62%
Lexaria Bioscience Corp. Lexaria Bioscience Corp.
$116,316 $29.83K
$2.891T +9,693,002,692.49%